NVO logo

Novo Nordisk A/S (NVO) Total liabilities

annual total liabilities:

$44.76B+$13.94B(+45.26%)
December 31, 2024

Summary

  • As of today (August 20, 2025), NVO annual total liabilities is $44.76 billion, with the most recent change of +$13.94 billion (+45.26%) on December 31, 2024.
  • During the last 3 years, NVO annual total liabilities has risen by +$25.83 billion (+136.51%).
  • NVO annual total liabilities is now at all-time high.

Performance

NVO Total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

quarterly total liabilities:

$49.42B-$1.35B(-2.66%)
June 1, 2025

Summary

  • As of today (August 20, 2025), NVO quarterly total liabilities is $49.42 billion, with the most recent change of -$1.35 billion (-2.66%) on June 1, 2025.
  • Over the past year, NVO quarterly total liabilities has increased by +$12.50 billion (+33.87%).
  • NVO quarterly total liabilities is now -2.66% below its all-time high of $50.77 billion, reached on March 31, 2025.

Performance

NVO quarterly total liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVObalance sheet metrics

Total liabilities Formula

Total Liabilities = Current Liabilities + Long-Term Liabilities

NVO Total liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+45.3%+33.9%
3 y3 years+136.5%+143.3%
5 y5 years+338.0%+331.1%

NVO Total liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+136.5%-2.7%+143.3%
5 y5-yearat high+338.0%-2.7%+331.1%
alltimeall timeat high>+9999.0%-2.7%>+9999.0%

NVO Total liabilities History

DateAnnualQuarterly
Jun 2025
-
$49.42B(-2.7%)
Mar 2025
-
$50.77B(+13.4%)
Dec 2024
$44.76B(+45.3%)
$44.76B(+8.0%)
Sep 2024
-
$41.46B(+12.3%)
Jun 2024
-
$36.91B(+27.5%)
Mar 2024
-
$28.96B(-6.0%)
Dec 2023
$30.81B(+36.1%)
$30.81B(+4.8%)
Sep 2023
-
$29.41B(+5.5%)
Jun 2023
-
$27.88B(+12.3%)
Mar 2023
-
$24.82B(+9.6%)
Dec 2022
$22.64B(+19.7%)
$22.64B(+3.4%)
Sep 2022
-
$21.89B(+7.8%)
Jun 2022
-
$20.31B(+4.0%)
Mar 2022
-
$19.53B(+3.2%)
Dec 2021
$18.92B(+41.1%)
$18.92B(+12.4%)
Sep 2021
-
$16.83B(+14.0%)
Jun 2021
-
$14.76B(+12.7%)
Mar 2021
-
$13.10B(-2.3%)
Dec 2020
$13.41B(+31.3%)
$13.41B(+5.9%)
Sep 2020
-
$12.66B(+10.5%)
Jun 2020
-
$11.46B(+8.5%)
Mar 2020
-
$10.57B(+3.4%)
Dec 2019
$10.22B(+13.2%)
$10.22B(-2.8%)
Sep 2019
-
$10.51B(+6.2%)
Jun 2019
-
$9.89B(+4.7%)
Mar 2019
-
$9.45B(+4.7%)
Dec 2018
$9.03B(+6.5%)
$9.03B(+6.6%)
Sep 2018
-
$8.47B(-0.2%)
Jun 2018
-
$8.49B(+4.3%)
Mar 2018
-
$8.14B(-4.0%)
Dec 2017
$8.47B(+14.3%)
$8.47B(+4.7%)
Sep 2017
-
$8.09B(+6.8%)
Jun 2017
-
$7.58B(-2.3%)
Mar 2017
-
$7.75B(+4.6%)
Dec 2016
$7.41B(+13.6%)
$7.41B(+6.8%)
Sep 2016
-
$6.94B(+1.8%)
Jun 2016
-
$6.82B(-1.1%)
Mar 2016
-
$6.90B(+5.7%)
Dec 2015
$6.53B(+9.2%)
$6.53B(+3.6%)
Sep 2015
-
$6.30B(-0.1%)
Jun 2015
-
$6.30B(-3.3%)
Mar 2015
-
$6.52B(+9.1%)
Dec 2014
$5.97B(+16.5%)
$5.97B(+5.7%)
Sep 2014
-
$5.65B(+13.9%)
Jun 2014
-
$4.96B(-9.4%)
Mar 2014
-
$5.47B(+6.7%)
Dec 2013
$5.13B(+15.9%)
$5.13B(-2.6%)
Sep 2013
-
$5.27B(+4.4%)
Jun 2013
-
$5.04B(+2.2%)
Mar 2013
-
$4.93B(+11.5%)
Dec 2012
$4.42B(-7.0%)
$4.42B(-17.2%)
Sep 2012
-
$5.34B(+5.6%)
Jun 2012
-
$5.06B(-2.0%)
Mar 2012
-
$5.16B(+8.5%)
Dec 2011
$4.76B
$4.76B(-0.7%)
Sep 2011
-
$4.79B(+0.4%)
DateAnnualQuarterly
Jun 2011
-
$4.77B(+3.5%)
Mar 2011
-
$4.61B(+4.8%)
Dec 2010
$4.40B(+30.0%)
$4.40B(+4.9%)
Sep 2010
-
$4.19B(+9.0%)
Jun 2010
-
$3.85B(-0.3%)
Mar 2010
-
$3.86B(+14.1%)
Dec 2009
$3.38B(+13.8%)
$3.38B(+5.6%)
Sep 2009
-
$3.21B(+8.6%)
Jun 2009
-
$2.95B(-4.2%)
Mar 2009
-
$3.08B(+3.6%)
Dec 2008
$2.97B(+16.5%)
$2.97B(+5.0%)
Sep 2008
-
$2.83B(-0.1%)
Jun 2008
-
$2.84B(-3.3%)
Mar 2008
-
$2.93B(+14.9%)
Dec 2007
$2.55B(+14.1%)
$2.55B(-0.2%)
Sep 2007
-
$2.56B(+10.1%)
Jun 2007
-
$2.32B(-0.7%)
Mar 2007
-
$2.34B(+4.6%)
Dec 2006
$2.24B(+5.3%)
$2.24B(-7.0%)
Sep 2006
-
$2.41B(+8.3%)
Jun 2006
-
$2.22B(+2.3%)
Mar 2006
-
$2.17B(+2.2%)
Dec 2005
$2.13B(+14.5%)
$2.13B(+4.1%)
Sep 2005
-
$2.04B(+11.3%)
Jun 2005
-
$1.84B(+3.3%)
Mar 2005
-
$1.78B(-4.3%)
Dec 2004
$1.86B(+19.5%)
$1.86B(+18.7%)
Sep 2004
-
$1.56B(+8.7%)
Jun 2004
-
$1.44B(-4.1%)
Mar 2004
-
$1.50B(-3.4%)
Dec 2003
$1.55B(+28.3%)
$1.55B(+1.8%)
Jun 2003
-
$1.53B(+13.9%)
Mar 2003
-
$1.34B(+10.6%)
Dec 2002
$1.21B(+15.3%)
$1.21B(+15.3%)
Dec 2001
$1.05B(-5.7%)
$1.05B(-4.5%)
Mar 2001
-
$1.10B(-1.3%)
Dec 2000
$1.11B(-33.3%)
$1.11B(+4.4%)
Dec 1999
$1.67B(+14.3%)
$1.07B(-26.8%)
Dec 1998
$1.46B(+33.7%)
$1.46B(+32.3%)
Dec 1997
$1.09B(+3.3%)
$1.10B(+4.6%)
Dec 1996
$1.06B(-9.1%)
$1.05B(+2.1%)
Dec 1995
$1.16B(-11.4%)
$1.03B(-21.5%)
Dec 1994
$1.31B(+22.8%)
$1.31B(+22.2%)
Dec 1993
$1.07B(+7.7%)
$1.08B(+8.2%)
Dec 1992
$994.16M(+1.9%)
$994.29M(+1.9%)
Dec 1991
$975.76M(+3.1%)
$975.82M(+3.1%)
Dec 1990
$946.71M(+15.7%)
$946.22M(+15.9%)
Dec 1989
$818.15M(+55.3%)
$816.44M(+51.8%)
Dec 1988
$526.67M(+5.0%)
$537.70M(+5.8%)
Dec 1987
$501.42M(+15.3%)
$508.19M(-8.4%)
Dec 1986
$434.77M(+59.9%)
$554.52M(+103.3%)
Dec 1985
$271.89M(+21.2%)
$272.73M(+21.2%)
Dec 1984
$224.37M(+16.0%)
$225.10M
Dec 1983
$193.39M(+5.9%)
-
Dec 1982
$182.70M(+2.7%)
-
Dec 1981
$177.84M(+3.8%)
-
Dec 1980
$171.27M
-

FAQ

  • What is Novo Nordisk A/S annual total liabilities?
  • What is the all time high annual total liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual total liabilities year-on-year change?
  • What is Novo Nordisk A/S quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly total liabilities year-on-year change?

What is Novo Nordisk A/S annual total liabilities?

The current annual total liabilities of NVO is $44.76B

What is the all time high annual total liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual total liabilities is $44.76B

What is Novo Nordisk A/S annual total liabilities year-on-year change?

Over the past year, NVO annual total liabilities has changed by +$13.94B (+45.26%)

What is Novo Nordisk A/S quarterly total liabilities?

The current quarterly total liabilities of NVO is $49.42B

What is the all time high quarterly total liabilities for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly total liabilities is $50.77B

What is Novo Nordisk A/S quarterly total liabilities year-on-year change?

Over the past year, NVO quarterly total liabilities has changed by +$12.50B (+33.87%)
On this page